Yüklüyor......
Molecular landscape and targeted therapy of acute myeloid leukemia
For decades, genetic aberrations including chromosome and molecular abnormalities are important diagnostic and prognostic factors in acute myeloid leukemia (AML). ATRA and imatinib have been successfully used in AML and chronic myelogenous leukemia, which proved that targeted therapy by identifying...
Kaydedildi:
| Yayımlandı: | Biomark Res |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BioMed Central
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6225571/ https://ncbi.nlm.nih.gov/pubmed/30455953 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40364-018-0146-7 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|